Second generation antipsychotics

Among insured patients initially prescribed second generation antipsychotics, monitoring of blood sugar and lipid levels falls very short of the 2004 American Diabetes Association (ADA) guidelines, researchers report. The guidelines are based on the considerable evidence that these medications can increase risk for cardiovascular disease by adversely affecting lipid and glucose metabolism as well as body weight. By 2006, the study showed just over 10% of patients that were newly prescribed second generation antipsychotics received lipid profile monitoring and just [...]